Researchers with UVA Health in Charlottesville, Virginia, have received $2.8 million from the National Institutes of Health (NIH) to continue work on a high-tech material that could boost care for hundreds of thousands of heart patients per year.

“Our approach is like deploying tiny guards to protect blood vessels from going bad, so that there is no need to open the body over and over again to repair them,” one specialist explained. 

Weekly doses of semaglutide, a GLP-1 receptor originally developed to treat diabetes, could help approximately 93 million U.S. adults lose weight and reduce their risk of adverse cardiovascular events, according to new research published in Cardiovascular Drugs and Therapy. Novo Nordisk sells and markets subcutaneous treatments of semaglutide 2.4 mg under the brand name Wegovy.

The FDA made a special announcement about its decision, describing the news as "a major advance for public health."

A majority of U.S. cardiologists would accept a cut in pay to achieve a significantly better work-life balance.

According to the same report, 43% of cardiologists with children said they feel conflicted about not spending enough time at home.

Nanoflex Robotics, a healthcare technology startup based out of Switzerland, has installed its remote-ready robotics system for neurovascular procedures in the United States for the first time

The new-look robotics system can help specialists perform remote mechanical thrombectomies from bedside or as far as thousands of miles away. 

Around the web

Eleven medical societies have signed on to a consensus statement aimed at standardizing imaging for suspected cardiovascular infections.

Kate Hanneman, MD, explains why many vendors and hospitals want to lower radiology's impact on the environment. "Taking steps to reduce the carbon footprint in healthcare isn’t just an opportunity," she said. "It’s also a responsibility."